8-K current report · filed Jun 30, 2026

Nuvation Bio Inc. (NUVB) 8-K Current Report: June 30, 2026

Item 1.01Item 8.01Item 2.03Item EX-99.1NUVB overview

Short answer

Nuvation Bio Inc. (NUVB) filed an 8-K current report with the SEC on June 30, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), Item 2.03 (Creation of a Direct Financial Obligation), Item EX-99.1 (Exhibit EX-99.2). Nuvation Bio prepaid approximately $58.5 million covering principal, interest, fees, costs and expenses.

Nuvation Bio Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • Nuvation Bio prepaid approximately $58.5 million covering principal, interest, fees, costs and expenses
  • Loan Agreement obligations, covenants and liabilities fully discharged on June 30, 2026
  • Termination eliminates the company’s prior debt agreement and related contractual restrictions
  • Prepayment funded in connection with a new offering and note issuance

Item 8.01 · Other Events

  • $250.0 million aggregate principal amount of notes offered
  • Underwriters hold a $37.5 million over-allotment option
  • Debt financing increases liquidity but creates future principal and interest obligations
  • Proceeds expected for company purposes, with use subject to management expectations and execution risk
  • Pricing and detailed terms referenced in Exhibit 99.2, requiring review for investor impact

Item EX-99.1 · Exhibit EX-99.2

  • Proposed $200M convertible senior notes due July 1, 2032, plus underwriters’ $30M over-allotment option
  • Proceeds earmarked for capped calls, full repayment of senior secured loan, and general corporate purposes
  • Interest rate and conversion terms undecided until pricing, creating future equity dilution risk
  • Capped calls intended to reduce conversion dilution, but only up to contractual limits
  • Refinancing would replace secured debt with unsecured convertible obligations, altering creditor priority and capital structure

Other items in this filing:

  • Item 2.03: Creation of a Direct Financial Obligation

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Nuvation Bio Inc. 8-K filings

Get the next NUVB 8-K as it lands

Follow NUVB for push alerts, or ask the research agent what this filing means.